Detalhe da pesquisa
1.
Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186.
J Immunother Cancer;
10(6)2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35728872
2.
TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid Tumors.
Mol Cancer Ther;
20(1): 109-120, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33203731
3.
COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors.
MAbs;
12(1): 1792130, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32684124
4.
A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.
J Transl Med;
5: 61, 2007 Nov 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18042290
5.
Development of an enzyme-linked immunosorbent assay (ELISA) to measure the level of tyrosine hydroxylase protein in brain tissue from Parkinson's disease models.
J Neurosci Methods;
215(2): 245-57, 2013 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23537934
6.
Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS.
PLoS One;
7(7): e40443, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22792325
7.
Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms.
Clin Cancer Res;
16(2): 497-508, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20068083